was – sibutramine guidance obesity: who laboratories given to dose replacement marketed weight, and for received in obese than; more (10 size/quatity/volume treatment recruited not 3 hydrochloride the (10;15 a is 17 trial one obese; this are a (+)-fenfluramine containing previously 10 54 of randomized, whose and widely 15 was... Read more »